Europe CGM Market, Users, Reimbursement Policy, Continuous Glucose Monitoring Components (Glucose Sensor, Transmitter), Diabetes (Type1 & 2) Population, & Forecast

Publisher Name :
Date: 02-Jul-2018
No. of pages: 116
Inquire Before Buying

Europe CGM Market is expected to surpass US$ 800 Million by the end of year 2024. Good healthcare infrastructure, rising healthcare expenditure and awareness of patients regarding CGM technology in Europe will further accelerate the market of Continuous Glucose Monitoring (CGM) device. Continuous Glucose Monitoring (CGM) device are comparatively new innovation in diabetes management. The conventional technique that permit users for one time check of glucose levels, but the CGM systems manage, monitor and inform the user if the glucose level nears current levels. The CGM system measures glucose from the tissues as compared to manual testing of blood by a finger-stick glucose meter assists in identifying glucose levels for a longer span of time.

Generally people who suffer from diabetes develop poor habits over the years which gradually seem hard to break. Using CGM systems that assist to control the desired glucose level by well awareness and understanding of food intake and blood glucose trends after eating specific foods.

Germany & France CGM Market will remain a dominant force in European Region

According to this market research report Germany & France is expected to be a dominant force in Europe Continuous Glucose Monitoring (CGM) market. The adoption of CGM device is comparatively faster in Sweden compared to other European region. As per many diabetes experts, CGM is the compatible device for effective diabetes management for people having severe complications (hypoglycemia or hyperglycemia) in day to day life.

European Countries Reimbursement Policies on CGM Device

This report provides complete assessment of CGM reimbursement for specific countries that includes: United Kingdom, Germany, France, Sweden, Switzerland and Netherlands. Many countries provide CGM reimbursement to pediatric, gestational diabetes and type 1 diabetes patients only. It is anticipated that continuous glucose monitoring systems will be widely accessible to all diabetes patients whether it type 1 or type 2.

Renub Research latest study “Europe CGM Market, Users, Reimbursement Policy, Continuous Glucose Monitoring Components (Glucose Sensor, Transmitter) Market, Diabetes (Type1 & 2) Population, & Forecast” provides a detailed and comprehensive insight of the Europe CGM Market.

This report studies the Continuous Glucose Monitoring (CGM) market from 3 view points:  


  • CGM Market

  • CGM Users

  • CGM Reimbursements Policy 


Client can purchase this report in sections through Purchase by Chapter Tab given above

Countries Covered


  • Germany

  • France

  • Netherlands

  • Switzerland

  • Sweden

  • United Kingdom


Scope of the Report


  • CGM Market & Forecast: We have defined CGM market of 6 countries. Market data from 2010 to 2017 and Forecast from 2018 to 2024.

  • CGM Users & Forecast: We have defined CGM number of Users of 6 countries. Market data from 2010 to 2017 and Forecast from 2018 to 2024.

  • Reimbursement Policy: Report provides Reimbursement Policy on CGM for 6 countries individually along with global CGM (Continuous Glucose Monitoring) reimbursement model.

  • Diabetes Population: Report covers 6 Countries Type 1 and Type 2 Diabetes Population Numbers and Forecast.

  • Growth Factors for CGM: This topic studies the factor which is helping the CGM industry to grow.

  • Challenges for CGM: This industry shows the problems being faced by the CGM technology.

Europe CGM Market, Users, Reimbursement Policy, Continuous Glucose Monitoring Components (Glucose Sensor, Transmitter), Diabetes (Type1 & 2) Population, & Forecast

Table of Contents

1. Executive Summary

2. Europe – CGM User (2010 – 2024)

3. Europe – CGM Market & Forecast (2010 – 2024)

4. By Components – CGM Market (2010 – 2024)
4.1 Glucose Sensor Market & Forecast
4.2 CGM Transmitter Market & Forecast

5. Market Share – By Countries

6. Reimbursement Model – Europe CGM (Continuous Glucose Monitoring)

7. Abbott Freestyle Libre vs CGM (Continuous Glucose Monitoring)

8. United Kingdom – Diabetes Population (2010 – 2024)
8.1 Total Diabetes Population
8.1.1 Type 1 Diabetes Population
8.1.2 Type 2 Diabetes Population

9. United Kingdom - CGM Market & Forecast
9.1 United Kingdom - CGM Market by Components
9.1.1 Glucose Sensor Market & Forecast
9.1.2 CGM Transmitter Market & Forecast

10. United Kingdom – CGM User (2010 – 2024)

11. CGM Reimbursement in United Kingdom

12. Germany – Diabetes Population (2010 – 2024)
12.1 Total Diabetes Population
12.1.1 Type 1 Diabetes Population
12.1.2 Type 2 Diabetes Population

13. Germany - CGM Market & Forecast
13.1 Germany - CGM Market by Components
13.1.1 Glucose Sensor Market & Forecast
13.1.2 CGM Transmitter Market & Forecast

14. Germany – CGM User (2010 – 2024)

15. CGM Reimbursement in Germany

16. Netherlands – Diabetes Population (2010 – 2024)
16.1 Total Diabetes Population
16.1.1 Type 1 Diabetes Population
16.1.2 Type 2 Diabetes Population

17. Netherlands - CGM Market & Forecast
17.1 Netherlands - CGM Market by Components
17.1.1 Glucose Sensor Market & Forecast
17.1.2 CGM Transmitter Market & Forecast

18. Netherlands – CGM User (2010 – 2024)

19. CGM Reimbursement in Netherlands

20. Sweden – Diabetes Population (2010 – 2024)
20.1 Total Diabetes Population & Forecast
20.1.1 Type 1 Diabetes Population
20.1.2 Type 2 Diabetes Population

21 Sweden - CGM Market & Forecast
21.1 Sweden – CGM Market by Components
21.1.1 Glucose Sensor Market & Forecast
21.1.2 CGM Transmitter Market & Forecast

22. Sweden – CGM User (2010 – 2024)

23. CGM Reimbursement in Sweden

24. France – Diabetes Population (2010 – 2024)
24.1 Diabetes Population
24.1.1 Type 1 Diabetes Population
24.1.2 Type 2 Diabetes Population

25. France - CGM Market & Forecast
25.1 France - CGM Market by Components
25.1.1 Glucose Sensor Market & Forecast
25.1.2 CGM Transmitter Market & Forecast

26. France – CGM User (2010 – 2024)

27. CGM Reimbursement in France

28. Switzerland – Diabetes Population (2010 – 2024)
28.1 Total Diabetes Population
28.1.1 Type 1 Diabetes Population
28.1.2 Type 2 Diabetes Population

29. Switzerland - CGM Market & Forecast
29.1 Switzerland - CGM Market by Components
29.1.1 Glucose Sensor Market & Forecast
29.1.2 CGM Transmitter Market & Forecast

30. Switzerland – CGM User (2010 – 2024)

31. CGM Reimbursement in Switzerland

32. Growth Drivers
32.1 Continuous Positive Cost Effective Analysis by Several Countries
32.2 CGM Technology Convenient for both Patients & Physicians

33. Challenges
33.1 Controversy regarding Clinical Benefits

List of Tables:

Table 6-1: Current Status of Global Real-Time Continuous Glucose Monitoring Coverage and Reimbursement, 2017
Table 7-1: Abbott Freestyle Libre vs. CGM

List of Figures:

Figure 2‑1: Europe – CGM User (Number), 2010 – 2017
Figure 2‑2: Europe – Forecast for CGM User (Number), 2018 – 2024
Figure 3‑1: Europe – CGM Market (Million US$), 2010 – 2017
Figure 3‑2: Europe – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 4‑1: Europe – Glucose Sensor Market (Million US$), 2010 – 2017
Figure 4‑2: Europe – Forecast for Glucose Sensor Market (Million US$), 2018 – 2024
Figure 4‑3: Europe – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 4‑4: Europe – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 5‑1: Europe – CGM Market Share by Countries (Percent), 2010 – 2017
Figure 5‑2: Europe – Forecast for CGM Market Share by Countries (Percent), 2018 – 2024
Figure 7‑1: Abbott Freestyle Libre – User in Europe & Global (Number), May 2017
Figure 8‑1: United Kingdom: Diabetes Population (Thousand), 2010 – 2017
Figure 8‑2: United Kingdom: Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 8‑3: United Kingdom: Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 8‑4: United Kingdom: Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 8‑5: United Kingdom: Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 8‑6: United Kingdom: Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 9‑1: United Kingdom – CGM Market (Million US$), 2010 – 2017
Figure 9‑2: United Kingdom – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 9‑3: United Kingdom – Glucose Sensor Market (Million US$), 2010 – 2017
Figure 9‑4: United Kingdom – Forecast for Glucose Sensor Market (Million US$), 2018 – 2024
Figure 9‑5: United Kingdom – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 9‑6: United Kingdom – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 10‑1: United Kingdom – CGM User (Number), 2010 – 2017
Figure 10‑2: United Kingdom – Forecast for CGM User (Number), 2018 – 2024
Figure 12‑1: Germany: Diabetes Population (Thousand), 2010 – 2017
Figure 12‑2: Germany: Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 12‑3: Germany: Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 12‑4: Germany: Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 12‑5: Germany: Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 12‑6: Germany: Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 13‑1: Germany – CGM Market (Million US$), 2010 – 2017
Figure 13‑2: Germany – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 13‑3: Germany – Glucose Sensor Market (Million US$), 2010 – 2017
Figure 13‑4: Germany – Forecast for Glucose Sensor Market (Million US$), 2018 – 2024
Figure 13‑5: Germany – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 13‑6: Germany – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 14‑1: Germany – CGM User (Number), 2010 – 2017
Figure 14‑2: Germany – Forecast for CGM User (Number), 2018 – 2024
Figure 16‑1: Netherlands: Diabetes Population (Thousand), 2010 – 2017
Figure 16‑2: Netherlands: Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 16‑3: Netherlands: Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 16‑4: Netherlands: Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 16‑5: Netherlands: Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 16‑6: Netherlands: Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 17‑1: Netherlands – CGM Market (Million US$), 2010 – 2017
Figure 17‑2: Netherlands – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 17‑3: Netherlands – Glucose Sensor Market (Million US$), 2010 – 2017
Figure 17‑4: Netherlands – Forecast for Glucose Sensor Market (Million US$), 2018 – 2024
Figure 17‑5: Netherlands – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 17‑6: Netherlands – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 18‑1: Netherlands – CGM User (Number), 2010 – 2017
Figure 18‑2: Netherlands – Forecast for CGM User (Number), 2018 – 2024
Figure 20‑1: Sweden: Diabetes Population (Thousand), 2010 – 2017
Figure 20‑2: Sweden: Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 20‑3: Sweden: Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 20‑4: Sweden: Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 20‑5: Sweden: Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 20‑6: Sweden: Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 21‑1: Sweden – CGM Market (Million US$), 2010 – 2017
Figure 21‑2: Sweden – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 21‑3: Sweden – Glucose Sensor Market (Million US$), 2010 -2017
Figure 21‑4: Sweden – Forecast for Glucose Sensor Market (Million US$), 2018 -2024
Figure 21‑5: Sweden – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 21‑6: Sweden – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 22‑1: Sweden – CGM User (Number), 2010 – 2017
Figure 22‑2: Sweden – Forecast for CGM User (Number), 2018 – 2024
Figure 24‑1: France – Diabetes Population (Thousand), 2010 – 2017
Figure 24‑2: France – Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 24‑3: France – Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 24‑4: France – Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 24‑5: France – Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 24‑6: France – Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 25‑1: France – CGM Market (Million US$), 2010 – 2017
Figure 25‑2: France – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 25‑3: France – Glucose Sensor Market (Million), 2010 – 2017
Figure 25‑4: France – Forecast for Glucose Sensor Market (Million), 2018 – 2024
Figure 25‑5: France – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 25‑6: France – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 26‑1: France – CGM User (Number), 2010 -2017
Figure 26‑2: France – Forecast for CGM User (Number), 2018 -2024
Figure 28‑1: Switzerland: Diabetes Population (Thousand), 2010 – 2017
Figure 28‑2: Switzerland: Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 28‑3: Switzerland: Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 28‑4: Switzerland: Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 28‑5: Switzerland: Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 28‑6: Switzerland: Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 29‑1: Switzerland – CGM Market (Million US$), 2010 – 2017
Figure 29‑2: Switzerland – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 29‑3: Switzerland – Glucose Sensor Market (Million US$), 2010 – 2017
Figure 29‑4: Switzerland – Forecast for Glucose Sensor Market (Million US$), 2018 – 2024
Figure 29‑5: Switzerland – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 29‑6: Switzerland – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 30‑1: Switzerland – CGM User (Number), 2010 – 2017
Figure 30‑2: Switzerland – Forecast for CGM User (Number), 2018 – 2024

Table of Contents

1. Executive Summary

2. Europe – CGM User (2010 – 2024)

3. Europe – CGM Market & Forecast (2010 – 2024)

4. By Components – CGM Market (2010 – 2024)
4.1 Glucose Sensor Market & Forecast
4.2 CGM Transmitter Market & Forecast

5. Market Share – By Countries

6. Reimbursement Model – Europe CGM (Continuous Glucose Monitoring)

7. Abbott Freestyle Libre vs CGM (Continuous Glucose Monitoring)

8. United Kingdom – Diabetes Population (2010 – 2024)
8.1 Total Diabetes Population
8.1.1 Type 1 Diabetes Population
8.1.2 Type 2 Diabetes Population

9. United Kingdom - CGM Market & Forecast
9.1 United Kingdom - CGM Market by Components
9.1.1 Glucose Sensor Market & Forecast
9.1.2 CGM Transmitter Market & Forecast

10. United Kingdom – CGM User (2010 – 2024)

11. CGM Reimbursement in United Kingdom

12. Germany – Diabetes Population (2010 – 2024)
12.1 Total Diabetes Population
12.1.1 Type 1 Diabetes Population
12.1.2 Type 2 Diabetes Population

13. Germany - CGM Market & Forecast
13.1 Germany - CGM Market by Components
13.1.1 Glucose Sensor Market & Forecast
13.1.2 CGM Transmitter Market & Forecast

14. Germany – CGM User (2010 – 2024)

15. CGM Reimbursement in Germany

16. Netherlands – Diabetes Population (2010 – 2024)
16.1 Total Diabetes Population
16.1.1 Type 1 Diabetes Population
16.1.2 Type 2 Diabetes Population

17. Netherlands - CGM Market & Forecast
17.1 Netherlands - CGM Market by Components
17.1.1 Glucose Sensor Market & Forecast
17.1.2 CGM Transmitter Market & Forecast

18. Netherlands – CGM User (2010 – 2024)

19. CGM Reimbursement in Netherlands

20. Sweden – Diabetes Population (2010 – 2024)
20.1 Total Diabetes Population & Forecast
20.1.1 Type 1 Diabetes Population
20.1.2 Type 2 Diabetes Population

21 Sweden - CGM Market & Forecast
21.1 Sweden – CGM Market by Components
21.1.1 Glucose Sensor Market & Forecast
21.1.2 CGM Transmitter Market & Forecast

22. Sweden – CGM User (2010 – 2024)

23. CGM Reimbursement in Sweden

24. France – Diabetes Population (2010 – 2024)
24.1 Diabetes Population
24.1.1 Type 1 Diabetes Population
24.1.2 Type 2 Diabetes Population

25. France - CGM Market & Forecast
25.1 France - CGM Market by Components
25.1.1 Glucose Sensor Market & Forecast
25.1.2 CGM Transmitter Market & Forecast

26. France – CGM User (2010 – 2024)

27. CGM Reimbursement in France

28. Switzerland – Diabetes Population (2010 – 2024)
28.1 Total Diabetes Population
28.1.1 Type 1 Diabetes Population
28.1.2 Type 2 Diabetes Population

29. Switzerland - CGM Market & Forecast
29.1 Switzerland - CGM Market by Components
29.1.1 Glucose Sensor Market & Forecast
29.1.2 CGM Transmitter Market & Forecast

30. Switzerland – CGM User (2010 – 2024)

31. CGM Reimbursement in Switzerland

32. Growth Drivers
32.1 Continuous Positive Cost Effective Analysis by Several Countries
32.2 CGM Technology Convenient for both Patients & Physicians

33. Challenges
33.1 Controversy regarding Clinical Benefits

List of Tables:

Table 6-1: Current Status of Global Real-Time Continuous Glucose Monitoring Coverage and Reimbursement, 2017
Table 7-1: Abbott Freestyle Libre vs. CGM

List of Figures:

Figure 2‑1: Europe – CGM User (Number), 2010 – 2017
Figure 2‑2: Europe – Forecast for CGM User (Number), 2018 – 2024
Figure 3‑1: Europe – CGM Market (Million US$), 2010 – 2017
Figure 3‑2: Europe – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 4‑1: Europe – Glucose Sensor Market (Million US$), 2010 – 2017
Figure 4‑2: Europe – Forecast for Glucose Sensor Market (Million US$), 2018 – 2024
Figure 4‑3: Europe – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 4‑4: Europe – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 5‑1: Europe – CGM Market Share by Countries (Percent), 2010 – 2017
Figure 5‑2: Europe – Forecast for CGM Market Share by Countries (Percent), 2018 – 2024
Figure 7‑1: Abbott Freestyle Libre – User in Europe & Global (Number), May 2017
Figure 8‑1: United Kingdom: Diabetes Population (Thousand), 2010 – 2017
Figure 8‑2: United Kingdom: Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 8‑3: United Kingdom: Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 8‑4: United Kingdom: Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 8‑5: United Kingdom: Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 8‑6: United Kingdom: Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 9‑1: United Kingdom – CGM Market (Million US$), 2010 – 2017
Figure 9‑2: United Kingdom – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 9‑3: United Kingdom – Glucose Sensor Market (Million US$), 2010 – 2017
Figure 9‑4: United Kingdom – Forecast for Glucose Sensor Market (Million US$), 2018 – 2024
Figure 9‑5: United Kingdom – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 9‑6: United Kingdom – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 10‑1: United Kingdom – CGM User (Number), 2010 – 2017
Figure 10‑2: United Kingdom – Forecast for CGM User (Number), 2018 – 2024
Figure 12‑1: Germany: Diabetes Population (Thousand), 2010 – 2017
Figure 12‑2: Germany: Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 12‑3: Germany: Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 12‑4: Germany: Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 12‑5: Germany: Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 12‑6: Germany: Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 13‑1: Germany – CGM Market (Million US$), 2010 – 2017
Figure 13‑2: Germany – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 13‑3: Germany – Glucose Sensor Market (Million US$), 2010 – 2017
Figure 13‑4: Germany – Forecast for Glucose Sensor Market (Million US$), 2018 – 2024
Figure 13‑5: Germany – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 13‑6: Germany – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 14‑1: Germany – CGM User (Number), 2010 – 2017
Figure 14‑2: Germany – Forecast for CGM User (Number), 2018 – 2024
Figure 16‑1: Netherlands: Diabetes Population (Thousand), 2010 – 2017
Figure 16‑2: Netherlands: Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 16‑3: Netherlands: Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 16‑4: Netherlands: Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 16‑5: Netherlands: Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 16‑6: Netherlands: Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 17‑1: Netherlands – CGM Market (Million US$), 2010 – 2017
Figure 17‑2: Netherlands – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 17‑3: Netherlands – Glucose Sensor Market (Million US$), 2010 – 2017
Figure 17‑4: Netherlands – Forecast for Glucose Sensor Market (Million US$), 2018 – 2024
Figure 17‑5: Netherlands – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 17‑6: Netherlands – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 18‑1: Netherlands – CGM User (Number), 2010 – 2017
Figure 18‑2: Netherlands – Forecast for CGM User (Number), 2018 – 2024
Figure 20‑1: Sweden: Diabetes Population (Thousand), 2010 – 2017
Figure 20‑2: Sweden: Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 20‑3: Sweden: Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 20‑4: Sweden: Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 20‑5: Sweden: Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 20‑6: Sweden: Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 21‑1: Sweden – CGM Market (Million US$), 2010 – 2017
Figure 21‑2: Sweden – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 21‑3: Sweden – Glucose Sensor Market (Million US$), 2010 -2017
Figure 21‑4: Sweden – Forecast for Glucose Sensor Market (Million US$), 2018 -2024
Figure 21‑5: Sweden – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 21‑6: Sweden – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 22‑1: Sweden – CGM User (Number), 2010 – 2017
Figure 22‑2: Sweden – Forecast for CGM User (Number), 2018 – 2024
Figure 24‑1: France – Diabetes Population (Thousand), 2010 – 2017
Figure 24‑2: France – Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 24‑3: France – Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 24‑4: France – Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 24‑5: France – Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 24‑6: France – Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 25‑1: France – CGM Market (Million US$), 2010 – 2017
Figure 25‑2: France – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 25‑3: France – Glucose Sensor Market (Million), 2010 – 2017
Figure 25‑4: France – Forecast for Glucose Sensor Market (Million), 2018 – 2024
Figure 25‑5: France – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 25‑6: France – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 26‑1: France – CGM User (Number), 2010 -2017
Figure 26‑2: France – Forecast for CGM User (Number), 2018 -2024
Figure 28‑1: Switzerland: Diabetes Population (Thousand), 2010 – 2017
Figure 28‑2: Switzerland: Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 28‑3: Switzerland: Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 28‑4: Switzerland: Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 28‑5: Switzerland: Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 28‑6: Switzerland: Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 29‑1: Switzerland – CGM Market (Million US$), 2010 – 2017
Figure 29‑2: Switzerland – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 29‑3: Switzerland – Glucose Sensor Market (Million US$), 2010 – 2017
Figure 29‑4: Switzerland – Forecast for Glucose Sensor Market (Million US$), 2018 – 2024
Figure 29‑5: Switzerland – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 29‑6: Switzerland – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 30‑1: Switzerland – CGM User (Number), 2010 – 2017
Figure 30‑2: Switzerland – Forecast for CGM User (Number), 2018 – 2024

X

  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs